Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Statement on FDA Distributor Licensure Proposed Rule
The Healthcare Distribution Alliance (HDA) released the following statement from President and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers.”
HDA Applauds Senate Passage of Maryland Legislation Designed To Clarify Role of Critical Pharmacy Partners
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the passage of SB 823 by the Maryland Senate.
Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the signing of SB 823 by Maryland Governor Larry Hogan.
HDA Statement on National Biodefense Strategy and Implementation Plan
The Healthcare Distribution Alliance (HDA) released the following statement in response to the Biden-Harris administration’s National Biodefense Strategy and Implementation Plan.
Nicolette A. Louissaint To Join HDA as Senior Vice President, Policy and Strategic Planning
The Healthcare Distribution Alliance (HDA) is pleased to announce that Nicolette A. Louissaint, PhD, MBA, has been named the organization’s Senior Vice President of Policy and Strategic Planning. In this newly created role, Louissaint will become a member of HDA’s Executive Management Team and report to President and Chief Executive Officer Chester “Chip” Davis, Jr. She will join HDA on January 18, 2022, from her current role serving as Executive Director and President of Healthcare Ready in Washington, D.C.